Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.0682USD
−12.13 MUSD
About VIVESTO AB
Sector
CEO
Erik Kinnman
Headquarters
Solna
Website
Employees (FY)
14
Founded
1988
FIGI
BBG009SYD7Y8
Vivesto AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand in 1999 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
